Related Experiment Video
Updated: Jun 4, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Stem cells in cardiovascular disease
Arshed A Quyyumi1, Jonathan Murrow
1Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30322, USA. aquyyum@emory.edu
Abstract:
Advances in stem cell biology over the past decade have fueled interest in new therapies for acute and chronic cardiovascular diseases. Pre-clinical work with a variety of cell types has suggested efficacy in improving ischemia and ventricular function, although mechanisms of effect remain to be fully explained. Human studies using certain cell types have shown modest clinical efficacy, while the safety of these experimental therapies supports continuing patient-oriented research.
Insights
Stem cell therapies show promise for cardiovascular diseases, improving heart function in preclinical studies. Human trials indicate modest efficacy and good safety, supporting further research into these innovative treatments.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Recent advances in stem cell biology have spurred interest in novel therapies for cardiovascular diseases.
- Preclinical research indicates potential benefits of various cell types for improving cardiac ischemia and function.
- Mechanisms underlying stem cell efficacy in cardiovascular repair require further elucidation.
Purpose of the Study:
- To review the current state of stem cell therapies for cardiovascular diseases.
- To assess the efficacy and safety of stem cell treatments based on preclinical and clinical data.
- To highlight the need for continued research in this field.
Main Methods:
- Review of preclinical studies investigating stem cell effects on ischemia and ventricular function.
- Analysis of human clinical trials evaluating stem cell therapy for cardiovascular conditions.
- Synthesis of evidence regarding the safety and efficacy of experimental cardiovascular cell therapies.
Main Results:
- Preclinical models suggest stem cells can improve cardiac ischemia and ventricular function.
- Human studies demonstrate modest clinical efficacy with certain cell types.
- The safety profile of these experimental therapies is generally favorable.
Conclusions:
- Stem cell therapy holds potential for treating acute and chronic cardiovascular diseases.
- Further patient-oriented research is warranted to optimize efficacy and fully understand mechanisms.
- The established safety supports continued investigation in clinical settings.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Multipotency of Hematopoietic Stem Cells
Mesenchymal Stem Cells
iPS Cell Differentiation
Embryonic Stem Cells

